Clinical Trial of #Tolvaptan in #Pediatric #ADPKD: Two-Year, Open-Label Extension
#VisualAbstract by @priti899
kireports.org/article/S2468-…
#VisualAbstract by @priti899
kireports.org/article/S2468-…
KIReports
@KIReports
Kidney International Reports | Official journal of @ISNkidneycare | Tweets by KI Reports Social Media team | 👀KIreportscommunity.org
352 Following 14K Followers 8.8K Posts
Latest posts 5
1/
Hey #NephTwitter!
Welcome to a 🆕 #tweetorial #xtorial brought to you by @KIReports
🦠Today, we're exploring BK polyomavirus-specific immunity and viral clearance after kidney transplantation. VA by @md_abdulqader83
Hey #NephTwitter!
Welcome to a 🆕 #tweetorial #xtorial brought to you by @KIReports
🦠Today, we're exploring BK polyomavirus-specific immunity and viral clearance after kidney transplantation. VA by @md_abdulqader83
Evaluating the Long-Term Risk of #KidneyFailure in #IgAN Using a #Real-World Population-Level Cohort From Canada
#VisualAbsract by @deniise_am
kireports.org/article/S2468-…
#VisualAbsract by @deniise_am
kireports.org/article/S2468-…
Clinical Trial of Open-Label #Mezagitamab in #IgAN: Final 96-Week Results
#VisualAbstract by @brian_rifkin
kireports.org/article/S2468-…
#VisualAbstract by @brian_rifkin
kireports.org/article/S2468-…
Access to #GeneticTesting in Patients With Suspected Genetic #Kidney #Disease in Europe
#VisualAbstract by @elbaonelida
kireports.org/article/S2468-…
#VisualAbstract by @elbaonelida
kireports.org/article/S2468-…
